Study Summary
This trial will develop a virtual ACT intervention for chronic pain (VACT-CP) for Veterans, which will utilize a personalized, social interface to address pain-related distress and functional difficulties of chronic pain.
Treatment Effectiveness
Study Objectives
2 Primary · 6 Secondary · Reporting Duration: Post-Intervention, at 8 weeks
Trial Safety
Trial Design
2 Treatment Groups
Waitlist Control Group
1 of 2
VACT-CP Group
1 of 2
Active Control
Experimental Treatment
40 Total Participants · 2 Treatment Groups
Primary Treatment: VACT-CP Group · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the objective of this research endeavor?
"The main measure used to gauge success of this trial is a Usability Survey at the 8-week Post-Intervention. Additionally, The Chronic Pain Values Inventory (CPVI), Pain Numeric Rating Scale and The Chronic Pain Acceptance Questionnaire (CPAQ) will also be employed as secondary outcome metrics. CPVI consists of 6 importance ratings from 0 to 5 and corresponding 6 success ratings which are averaged together for a score ranging from 1 - 6; whereas, CPAQ has an Activity Engagement subscale with 11 items scaling up to 77 points, in addition to 9 items on the Pain Willingness scale that can reach" - Anonymous Online Contributor
How many participants can be involved in this research endeavor?
"Affirmative. According to clinicaltrials.gov, this experimental trial is currently enrolling participants since its inception on March 17th 2022 and last revised on May 2nd 2022. The study requires 40 volunteers that can be recruited from two different sites." - Anonymous Online Contributor
Are there any vacancies still available for potential participants of this research?
"Affirmative. Clinicaltrials.gov data suggests that this trial is presently recruiting participants, which began on March 17th 2022 and was last modified on May 2nd 2022. The study requires 40 patients to be enrolled at two separate sites." - Anonymous Online Contributor